# Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy

> **NCT00166868** · NA · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Biliary Atresia

## Interventions

- **DRUG:** Lactobacillus casei rhamnosus (Lcr35)
- **DRUG:** Neomycin

## Key facts

- **NCT ID:** NCT00166868
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2012-01
- **Final completion:** 2012-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00166868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00166868, "Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00166868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*